GlassScriptPhysician profile
Chad Michael Cravatta
NPI 1457579302
$2,383.03
in general payments reported to CMS, 2019-2025
14 companies · $564 in 2025
The $564 reported for 2025 was more than what 84% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $230 · 2021: $171 · 2022: $19.93 · 2023: $176 · 2024: $783 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Entertainment: $788 · Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Entertainment | $788.29 |
| Food and Beverage | $734.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Keystone Dental INC. | $850.45 | 2020-2025 | |
| Nobel Biocare USA | $406.42 | 2019-2023 | Nobelactive |
| Biohorizons Implant Systems INC. | $313.83 | 2022-2025 | Biohorizons, Biohorizons Dental Implants |
| Geistlich Pharma, North America, INC. | $183.79 | 2024 | Geistlich Bio-Gide |
| Dentsply Sirona INC | $173.51 | 2019-2024 | Astra Tech Implant System |
| Zimvie INC. | $156.45 | 2025 | |
| Salvin Dental Specialties, INC. | $103.60 | 2019-2021 | |
| Ace Surgical Supply Co., INC. | $54.88 | 2020-2021 | |
| Straumann USA LLC | $34.84 | 2019 | |
| Solventum Corporation | $28.86 | 2025 | 3m Relyx |
| Zyla Life Sciences, INC. | $26.24 | 2020 | |
| Align Technology, INC. | $22.91 | 2024 | Invisalign |
| Gc America INC. | $14.84 | 2019 | |
| Zimmer Biomet Holdings, INC. | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Cravatta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.